This paper explores the role of these technologies in developing personalized mRNA vaccines, focusing on genome sequencing, epitope prediction, RNA structure analysis, and LNP formulation. We discuss ...

In 2023, the company commenced a Phase I/II trial to assess the immune response and safety of pandemic influenza vaccine. Credit: pcruciatti/Shutterstock. Moderna is set to receive $590m in funding ...

mRNA vaccines, pivotal in the fight against COVID-19, are now emerging as a promising innovation in cancer treatment. As clinical trials advance, Ben Hargreaves finds the technology is poised to ...

VISION Network researchers report that across the board these ... New mRNA Vaccine Created to Prevent and Treat C. Difficile Oct. 17, 2024 — A new vaccine provides hope for treating and even ...

In this review of RNA therapies, we paint an overview of what’s going on in a field that is addressing a number of diseases.

The 25,000-subject study is testing a nucleoside-modified mRNA (modRNA), quadrivalent vaccine that is targeted against four strains of the flu virus that the World Health Organization (WHO ...

The funding, which follows the $176 million the government awarded Moderna in June 2024, aims to get mRNA vaccines ready before bird flu strains currently circulating in the wild and on farms can ...

In an effort to combat the growing threat of monkeypox (mpox), scientists from Türkiye and the United Kingdom have joined ...

8, 2025 /PRNewswire/ -- The COVID-19 pandemic has fundamentally transformed global healthcare systems and vaccine technologies. The accelerated approval and rapid distribution of mRNA vaccines ...

The U.S. government previously awarded the vaccine manufacturer $176 million in July 2024 to help expedite the development of an mRNA vaccine that could be used for bird flu. mRNA technology is ...

Here the authors analyze data from COVAIL trial participants receiving an mRNA second COVID-19 vaccine boost and show that, while neutralizing antibody titer is correlated with Omicron COVID-19 ...